Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2017

09.06.2017 | Retinal Disorders

The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy

verfasst von: Robert Hoerster, Sascha Fauser, Claus Cursiefen, Bernd Kirchhof, Ludwig M. Heindl

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The renin-angiotensin system is involved in the pathogenesis of fibrosis in several organs via induction of transforming growth factor (TGF) beta. In the pathogenesis of proliferative vitreoretinopathy (PVR) TGF-beta plays a pivotal role, promoting transition of retinal pigment epithelial (RPE) cells into myofibroblasts. We studied the influence of angiotensin converting enzyme-inhibition (ACEI) on cytokines and growth factors, related to PVR in aqueous humor.

Methods

We performed a post hoc analysis of a prospectively conducted interventional case series. From patients with rhegmatogenous retinal detachment (RRD) aqueous humor was obtained during primary surgery and analyzed using multiplex bead analysis for interferon gamma, tumor necrosis factor alpha, CC-chemokine ligand (CCL) 2 / monocyte chemoattractant protein (MCP)-1, interleukin (IL)-1 beta, IL-2, IL-4, IL-6, IL-8, vascular endothelial growth factor (VEGF)-A, platelet derived growth factor (PDGF)-aa, TGF-beta 1, TGF-beta 2, TGF-beta 3, fibroblast growth factor (FGF)-aa, and FGF-bb. We recorded information about systemic ACEI from the medical history.

Results

In the primary study elevated levels of TGF-beta 1 and 2, IL 6 and 8 and CCL2/MCP-1 were a risk factor for later PVR development. Here, systemic ACEI neither influenced levels of these cytokines and growth factors, nor of any other tested in this study (p ≥ 0.438, respectively). Also the incidence of PVR development was unaffected (p = 0.201).

Conclusion

The systemic intake of ACEI for arterial hypertension does not influence levels of profibrotic cytokines/growth factors in aqueous humor. Further studies need to clarify if relevant levels of ACEI accumulate in the eye, and if direct administration of ACEI in experimental PVR could be beneficial.
Literatur
1.
Zurück zum Zitat Glaser BM, Cardin A, Biscoe B (1987) Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology 94:327–332CrossRefPubMed Glaser BM, Cardin A, Biscoe B (1987) Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology 94:327–332CrossRefPubMed
2.
3.
Zurück zum Zitat Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ (2000) TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 41:2336–2342PubMed Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ (2000) TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 41:2336–2342PubMed
4.
Zurück zum Zitat Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M et al (1989) Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83:1661–1666CrossRefPubMedPubMedCentral Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M et al (1989) Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 83:1661–1666CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Gamulescu MA, Chen Y, He S, Spee C, Jin M, Ryan SJ, Hinton DR (2006) Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 83:212–222CrossRefPubMed Gamulescu MA, Chen Y, He S, Spee C, Jin M, Ryan SJ, Hinton DR (2006) Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 83:212–222CrossRefPubMed
6.
Zurück zum Zitat Hoerster R, Hermann MM, Rosentreter A, Muether PS, Kirchhof B, Fauser S (2013) Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Br J Ophthalmol 97:450–453CrossRefPubMed Hoerster R, Hermann MM, Rosentreter A, Muether PS, Kirchhof B, Fauser S (2013) Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment. Br J Ophthalmol 97:450–453CrossRefPubMed
7.
Zurück zum Zitat Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H, Hafezi-Moghadam A, Ishibashi T (2008) Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A 105:17504–17509CrossRefPubMedPubMedCentral Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H, Hafezi-Moghadam A, Ishibashi T (2008) Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A 105:17504–17509CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Nassar K, Grisanti S, Tura A, Luke J, Luke M, Soliman M, Grisanti S (2014) A TGF-beta receptor 1 inhibitor for prevention of proliferative vitreoretinopathy. Exp Eye Res 123:72–86CrossRefPubMed Nassar K, Grisanti S, Tura A, Luke J, Luke M, Soliman M, Grisanti S (2014) A TGF-beta receptor 1 inhibitor for prevention of proliferative vitreoretinopathy. Exp Eye Res 123:72–86CrossRefPubMed
9.
Zurück zum Zitat Hoerster R, Muether PS, Vierkotten S, Hermann MM, Kirchhof B, Fauser S (2014) Upregulation of TGF-ss1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition. Graefes Arch Clin Exp Ophthalmol 252:11–16CrossRefPubMed Hoerster R, Muether PS, Vierkotten S, Hermann MM, Kirchhof B, Fauser S (2014) Upregulation of TGF-ss1 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition. Graefes Arch Clin Exp Ophthalmol 252:11–16CrossRefPubMed
10.
Zurück zum Zitat Lee H, O’Meara SJ, O’Brien C, Kane R (2007) The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 48:4291–4299CrossRefPubMed Lee H, O’Meara SJ, O’Brien C, Kane R (2007) The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 48:4291–4299CrossRefPubMed
11.
Zurück zum Zitat Nassar K, Luke J, Luke M, Kamal M, Abd El-Nabi E, Soliman M, Rohrbach M, Grisanti S (2011) The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol 249:1649–1660CrossRefPubMed Nassar K, Luke J, Luke M, Kamal M, Abd El-Nabi E, Soliman M, Rohrbach M, Grisanti S (2011) The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol 249:1649–1660CrossRefPubMed
12.
Zurück zum Zitat Hatanaka H, Koizumi N, Okumura N, Kay EP, Mizuhara E, Hamuro J, Kinoshita S (2012) Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-beta are prevented by PPAR-gamma agonists. Invest Ophthalmol Vis Sci 53:6955–6963CrossRefPubMed Hatanaka H, Koizumi N, Okumura N, Kay EP, Mizuhara E, Hamuro J, Kinoshita S (2012) Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-beta are prevented by PPAR-gamma agonists. Invest Ophthalmol Vis Sci 53:6955–6963CrossRefPubMed
13.
Zurück zum Zitat Parapuram SK, Chang B, Li L, Hartung RA, Chalam KV, Nair-Menon JU, Hunt DM, Hunt RC (2009) Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 50:5965–5974CrossRefPubMed Parapuram SK, Chang B, Li L, Hartung RA, Chalam KV, Nair-Menon JU, Hunt DM, Hunt RC (2009) Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 50:5965–5974CrossRefPubMed
14.
Zurück zum Zitat Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D (2000) Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301–2313CrossRefPubMed Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D (2000) Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301–2313CrossRefPubMed
15.
Zurück zum Zitat El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR, Vaughan ED Jr, Poppas DP, Felsen D (2007) Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292:F1291–F1301CrossRefPubMed El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR, Vaughan ED Jr, Poppas DP, Felsen D (2007) Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292:F1291–F1301CrossRefPubMed
16.
Zurück zum Zitat Sun N, Zhai L, Li H, Shi LH, Yao Z, Zhang B (2016) Angiotensin-converting enzyme inhibitor (ACEI)-mediated amelioration in renal fibrosis involves suppression of mast cell degranulation. Kidney Blood Press Res 41:108–118CrossRefPubMed Sun N, Zhai L, Li H, Shi LH, Yao Z, Zhang B (2016) Angiotensin-converting enzyme inhibitor (ACEI)-mediated amelioration in renal fibrosis involves suppression of mast cell degranulation. Kidney Blood Press Res 41:108–118CrossRefPubMed
17.
Zurück zum Zitat Schroder S, Muether PS, Caramoy A, Hahn M, Abdel-Salam M, Diestelhorst M, Kirchhof B, Fauser S (2012) Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Retina 32:38–42CrossRefPubMed Schroder S, Muether PS, Caramoy A, Hahn M, Abdel-Salam M, Diestelhorst M, Kirchhof B, Fauser S (2012) Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment. Retina 32:38–42CrossRefPubMed
18.
Zurück zum Zitat Ramirez M, Davidson EA, Luttenauer L, Elena PP, Cumin F, Mathis GA, De Gasparo M (1996) The renin-angiotensin system in the rabbit eye. J Ocul Pharmacol Ther 12:299–312CrossRefPubMed Ramirez M, Davidson EA, Luttenauer L, Elena PP, Cumin F, Mathis GA, De Gasparo M (1996) The renin-angiotensin system in the rabbit eye. J Ocul Pharmacol Ther 12:299–312CrossRefPubMed
19.
Zurück zum Zitat Wolf G, Zahner G, Schroeder R, Stahl RA (1996) Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 11:263–269CrossRefPubMed Wolf G, Zahner G, Schroeder R, Stahl RA (1996) Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells. Nephrol Dial Transplant 11:263–269CrossRefPubMed
20.
Zurück zum Zitat Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1996) Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885–892CrossRefPubMed Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1996) Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885–892CrossRefPubMed
21.
Zurück zum Zitat Heindl LM, Schlotzer-Schrehardt U, Cursiefen C, Bachmann BO, Hofmann-Rummelt C, Kruse FE (2011) Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am J Ophthalmol 151:1019–1023 e1012CrossRefPubMed Heindl LM, Schlotzer-Schrehardt U, Cursiefen C, Bachmann BO, Hofmann-Rummelt C, Kruse FE (2011) Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am J Ophthalmol 151:1019–1023 e1012CrossRefPubMed
22.
Zurück zum Zitat Matthaei M, Gillessen J, Muether PS, Hoerster R, Bachmann BO, Hueber A, Cursiefen C, Heindl LM (2015) Epithelial-mesenchymal transition (EMT)-related cytokines in the aqueous humor of Phakic and Pseudophakic Fuchs’ dystrophy eyes. Invest Ophthalmol Vis Sci 56:2749–2754CrossRefPubMed Matthaei M, Gillessen J, Muether PS, Hoerster R, Bachmann BO, Hueber A, Cursiefen C, Heindl LM (2015) Epithelial-mesenchymal transition (EMT)-related cytokines in the aqueous humor of Phakic and Pseudophakic Fuchs’ dystrophy eyes. Invest Ophthalmol Vis Sci 56:2749–2754CrossRefPubMed
Metadaten
Titel
The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy
verfasst von
Robert Hoerster
Sascha Fauser
Claus Cursiefen
Bernd Kirchhof
Ludwig M. Heindl
Publikationsdatum
09.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2017
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3707-9

Weitere Artikel der Ausgabe 9/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.